(Q72962746)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6291362%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

title

Acute and long-term effects of captopril on exercise cardiac performance and exercise capacity in congestive heart failure (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6291362%20AND%20SRC:MED&resulttype=core&format=json

Cardiology and cardiovascular medicine

30 October 2019

main subject

congestive heart failure

1 reference

based on heuristic

inferred from title

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90047-3

18 September 2023

author name string

N. Topic

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6291362

18 September 2023

B. Kramer

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6291362

18 September 2023

B. Massie

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6291362

18 September 2023

language of work or name

English

0 references

publication date

1 November 1982

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6291362%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

30 October 2019

https://api.elsevier.com/content/article/PII:0002870382900473?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90047-3

https://api.elsevier.com/content/article/PII:0002870382900473?httpAccept=text/plain

18 September 2023

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90047-3

18 September 2023

published in

American Heart Journal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6291362%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

volume

104

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6291362%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

issue

5 Pt 2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6291362%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

page(s)

1172-1179

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6291362%20AND%20SRC:MED&resulttype=core&format=json

Hydralazine in the management of left ventricular failure

30 October 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90047-3

Oral hydralazine in chronic heart failure: sustained beneficial hemodynamic effects

18 September 2023

2

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90047-3

Acute and long-term effects of vasodilator therapy on resting and exercise hemodynamics and exercise tolerance

18 September 2023

3

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90047-3

Beneficial hemodynamic response to chronic prazosin therapy in congestive heart failure

18 September 2023

4

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90047-3

Therapeutic application of prazosin in chronic refractory congestive heart failure. Tolerance and "tachyphylaxis" in perspective

18 September 2023

5

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90047-3

Sustained hemodynamic effects without tolerance during long-term isosorbide dinitrate treatment of chronic left ventricular failure

18 September 2023

6

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90047-3

Hemodynamic effects of orally administered isosorbide dinitrate in patients with congestive heart failure.

18 September 2023

7

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90047-3

Hemodynamic effects of nitroglycerin ointment in congestive heart failure

18 September 2023

8

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90047-3

Oral hydralazine therapy for chronic refractory heart failure

18 September 2023

9

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90047-3

Hemodynamic improvement after oral hydralazine in left ventricular failure: a comparison with nitroprusside infusion in 16 patients

18 September 2023

10

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90047-3

Hemodynamic advantage of combined administration of hydralazine orally and nitrates nonparenterally in the vasodilator therapy of chronic heart failure

18 September 2023

11

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90047-3

Sustained reduction of cardiac impedance and preload in congestive heart failure with the antihypertensive vasodilator prazosin

18 September 2023

12

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90047-3

Hemodynamic effects of trimazosin in patients with left ventricular failure

18 September 2023

13

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90047-3

Effects of minoxidil on hemodynamics in patients with congestive heart failure.

18 September 2023

14

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90047-3

Immediate and sustained hemodynamic and clinical improvement in chronic heart failure by an oral angiotensin-converting enzyme inhibitor

18 September 2023

15

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90047-3

Treatment of Chronic Congestive Heart Failure with Captopril, an Oral Inhibitor of Angiotensin-Converting Enzyme

18 September 2023

16

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90047-3

Renin, aldosterone and cardiac decompensation: Studies with an oral converting enzyme inhibitor in heart failure

18 September 2023

17

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90047-3

Acute and long-term response to an oral converting-enzyme inhibitor, captopril, in congestive heart failure

18 September 2023

18

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90047-3

Sustained Effectiveness of Converting-Enzyme Inhibition in Patients with Severe Congestive Heart Failure

18 September 2023

19

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90047-3

Efficacy of oral angiotensin-converting enzyme inhibition with captopril therapy in severe chronic normotensive congestive heart failure

18 September 2023

20

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90047-3

Angiotensin inhibition in severe heart failure: acute central and limb hemodynamic effects of captopril with observations on sustained oral therapy

18 September 2023

21

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90047-3

Long-term hemodynamic and clinical efficacy of captopril therapy in ambulatory management of severe chronic congestive heart failure

18 September 2023

22

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90047-3

Renin-angiotensin system: biochemistry and mechanisms of action

18 September 2023

23

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90047-3

Comparison of Effects of Angiotensin and Norepinephrine on Pulmonary Circulation, Systemic Arteries and Veins, and Systemic Vascular Capacity in the Dog

18 September 2023

24

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90047-3

Hydrolysis of bradykinin and its higher homologues by angiotensin-converting enzyme

18 September 2023

26

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90047-3

Action of angiotensin on vascular adrenergic nerve endings: facilitation of norepinephrine release

18 September 2023

27

1 reference

https://api.crossref.org/works/10.1016/0002-8703(82)90047-3

18 September 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6291362%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

1 reference